Search

everythinglearnresearchcommunity

for

Search:↓

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Some breast cancer chemotherapy can cause permanent hair loss.

Skin problems are very common in people with end-stage kidney disease.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.